Trial · NCT02090959
Results by group82
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 82
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Any AEs | 202 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | SAEs | 24 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Drug-Related AEs | 44 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | AEs Leading to Withdrawal From Study | 1 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Mild AEs | 87 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Moderate AEs | 71 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Severe AEs | 42 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Life-threatening AEs | 2 | Participants | |
| Number of Participants With Abnormalities in Clinical Laboratory Parameters | Ataluren | 29 | Participants | ||
| Change From Baseline in 6MWD at Week 144 | Ataluren | -98.18 | Standard Deviation 86.604 | meters | |
| Change From Baseline in Time to Stand From Supine Position at Week 144 | Ataluren | 5.22 | Standard Deviation 5.104 | seconds | |
| Change From Baseline in Time to Walk/Run 10 Meters at Week 144 | Ataluren | 2.29 | Standard Deviation 1.991 | seconds | |
| Change From Baseline in Time to Climb 4 Stairs at Week 144 | Ataluren | 4.01 | Standard Deviation 7.260 | seconds | |
| Change From Baseline in Time to Descend 4 Stairs at Week 144 | Ataluren | 2.45 | Standard Deviation 5.853 | seconds | |
| Change From Baseline in Physical Function Total Score as Measured by NSAA at Week 144 | Ataluren | -7.95 | Standard Deviation 5.611 | units on a scale | |
| Change From Baseline in PUL Total Score at Week 144 | Ataluren | -4.0 | Standard Deviation 7.49 | units on a scale | |
| Change From Baseline in Percent Predicted FVC as Measured by Spirometry at Week 144 | Ataluren | 3.51 | Standard Deviation 14.253 | percent predicted FVC | |
| Change From Baseline in Percent Predicted FEV1 as Measured by Spirometry at Week 144 | Ataluren | 1.40 | Standard Deviation 15.319 | percent predicted FEV1 | |
| Change From Baseline in PEF as Measured by Spirometry at Week 144 | Ataluren | 0.23 | Standard Deviation 1.099 | L/sec | |
| Change From Baseline in PCF as Measured by Spirometry at Week 144 | Ataluren | 0.53 | Standard Deviation 1.281 | L/sec |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02090959/results